Global POC Molecular Diagnostics Market 2017-2021 - Product Image

Global POC Molecular Diagnostics Market 2017-2021

  • ID: 4430328
  • Report
  • Region: Global
  • 113 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abbott
  • bioMérieux
  • Devyser
  • GenePOC
  • Micronics
  • PathoQuest
  • MORE
About POC Molecular Diagnostics

POC molecular diagnostics help in identification, treatment, and prevention of infectious diseases, oncology, hematology, and prenatal diseases. The demand for POC molecular diagnostic products is increasing owing to the highly developed technologies, which are used to detect and amplify deoxyribonucleic acid (DNA)/RNA. The major factor driving the growth of this market is the increasing prevalence of pandemic diseases such as Ebola and Zika. Based on the reports by the Centers for Disease Control and Prevention (CDC) in March 2016, in Guinea and Liberia (Africa), 13 cases of Ebola were reported whereas more than 1,200 population came into contact with the virus.

The analysts forecast the global POC molecular diagnostics market to grow at a CAGR of 12.83% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global POC molecular diagnostics market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, Global POC Molecular Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Abbott
  • bioMérieux
  • Danaher
  • F. Hoffmann-La Roche
Other prominent vendors
  • Agilent Technologies
  • Akonni Biosystems
  • altona Diagnostics
  • Atlas Genetics
  • BD
  • Bionano Genomics
  • BJS Biotechnologies
  • Certest Biotec
  • Co-Diagnostics
  • Devyser
  • Diagenode
  • DiaSorin
  • ExcitePCR
  • genedrive
  • GenePOC
  • iCubate
  • Illumina
  • Merck
  • Meridian Bioscience
  • Mesa Biotech
  • Micronics
  • Nanobiosym
  • NeoGenomics
  • Nimagen
  • Novigenix
  • OraSure Technologies
  • Oxford Nanopore Technologies
  • PathoQuest
  • PierianDx
  • Precision System Science
  • QuantuMDx
  • Randox Laboratories
  • SCIENION
  • Seegene
  • SpeeDX
  • Sysmex
  • Xagenic
Market drivers
  • Increased companies' participation in conferences to showcase their products
  • For a full, detailed list, view the full report
Market challenges
  • Low adoption among healthcare providers
  • For a full, detailed list, view the full report
Market trends
  • Growing focus on next-generation products
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott
  • bioMérieux
  • Devyser
  • GenePOC
  • Micronics
  • PathoQuest
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: INTRODUCTION
  • Market outline
PART 05: MARKET LANDSCAPE
  • Market size and forecast
  • Five forces analysis
PART 06: MARKET SEGMENTATION BY APPLICATION
  • Infectious diseases
  • Oncology
  • Hematology and endocrinology
  • Others (prenatal and cardiac)
PART 07: MARKET SEGMENTATION BY TECHNOLOGY
  • PCR (gene sequencing)
  • Microarray and hybridization
PART 08: MARKET SEGMENTATION BY END-USER
  • Market overview
  • Hospital and clinics
  • Diagnostic laboratories
  • Research institutes
PART 09: REGIONAL LANDSCAPE
  • Geographical segmentation
  • Regional comparison
  • POC molecular diagnostics market in Americas
  • POC molecular diagnostics market in EMEA
  • POC molecular diagnostics market in APAC
  • Market opportunity
PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 12: MARKET TRENDS
  • Growing focus on next-generation products
  • Liquid biopsy as an emerging trend
  • Paradigm shift toward miRNAs
PART 13: VENDOR LANDSCAPE
  • Competitive landscape
PART 14: KEY VENDOR ANALYSIS
  • Abbott
  • bioMérieux
  • Danaher
  • F. Hoffmann-La Roche
  • Key companies to watch
  • Other prominent vendors
PART 15: APPENDIX
  • List of abbreviations
List of Exhibits
Exhibit 01: Difference between POC molecular diagnostic test and conventional testing process
Exhibit 02: Market overview: Global POC molecular diagnostics market 2017-2021
Exhibit 03: Global POC molecular diagnostics market 2016-2021 ($ millions)
Exhibit 04: Five forces analysis
Exhibit 05: Market share: Global POC molecular diagnostics market by application 2016
Exhibit 06: Market overview: Global POC molecular diagnostics market by infectious diseases
Exhibit 07: Market overview: Global POC molecular diagnostics market by oncology
Exhibit 08: Market share: Global POC molecular diagnostics market by technology
Exhibit 09: Market outlook of PCR (gene sequencing)
Exhibit 10: Overview of global POC molecular diagnostics market by PCR (gene sequencing)
Exhibit 11: Global POC molecular diagnostics market by PCR (gene sequencing) 2016-2021 ($ millions)
Exhibit 12: Overview of global POC molecular diagnostics market by microarray and hybridization
Exhibit 13: Global POC molecular diagnostics market by microarray and hybridization 2016-2021 ($ millions)
Exhibit 14: Global POC molecular diagnostics market by end-users: Strategic analysis 2016
Exhibit 15: Global POC molecular diagnostics market by geography 2016-2021 (%)
Exhibit 16: Regional comparison
Exhibit 17: POC molecular diagnostics market in Americas 2016-2021 ($ millions)
Exhibit 18: POC molecular diagnostics market in Americas: Year-over-year growth 2017-2021 (%)
Exhibit 19: Top 3 countries in Americas
Exhibit 20: POC molecular diagnostics market in EMEA 2016-2021 ($ millions)
Exhibit 21: POC molecular diagnostics market in EMEA: Year-over-year growth 2017-2021 (%)
Exhibit 22: Top 3 countries in EMEA
Exhibit 23: POC molecular diagnostics market in APAC 2016-2021 ($ millions)
Exhibit 24: POC molecular diagnostics market in APAC: Year-over-year growth 2017-2021 (%)
Exhibit 25: Top 3 countries in APAC
Exhibit 26: Competitive structure analysis of global POC molecular diagnostics market 2016
Exhibit 27: Strategic factors of companies in global POC molecular diagnostics market 2016
Exhibit 28: Abbott: Key highlights
Exhibit 29: Abbott: Strength assessment
Exhibit 30: Abbott: Strategy assessment
Exhibit 31: Abbott: Opportunity assessment
Exhibit 32: bioMérieux: Key highlights
Exhibit 33: bioMérieux: Strength assessment
Exhibit 34: bioMérieux: Strategy assessment
Exhibit 35: bioMérieux: Opportunity assessment
Exhibit 36: Danaher: Key highlights
Exhibit 37: Danaher: Strength assessment
Exhibit 38: Danaher: Strategy assessment
Exhibit 39: Danaher: Opportunity assessment
Exhibit 40: F. Hoffmann-La Roche: Key highlights
Exhibit 41: F. Hoffmann-La Roche: Strength assessment
Exhibit 42: F. Hoffmann-La Roche: Strategy assessment
Exhibit 43: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 44: Bio-Rad Laboratories: Company assessment
Exhibit 45: QIAGEN: Company assessment
Exhibit 46: Quidel: Company assessment
Exhibit 47: Thermo Fisher Scientific: Company assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott
  • bioMérieux
  • Devyser
  • GenePOC
  • Micronics
  • PathoQuest
  • MORE
New Report Released: - Global POC Molecular Diagnostics Market 2017-2021

The author of the report recognizes the following companies as the key players in the global POC molecular diagnostics market: Abbott, bioMérieux, Danaher, and F. Hoffmann-La Roche.

Other Prominent Vendors in the market are: Agilent Technologies, Akonni Biosystems, altona Diagnostics, Atlas Genetics, BD, Bionano Genomics, BJS Biotechnologies, Certest Biotec, Co-Diagnostics, Devyser, Diagenode, DiaSorin, ExcitePCR, genedrive, GenePOC, iCubate, Illumina, Merck, Meridian Bioscience, Mesa Biotech, Micronics, Nanobiosym, NeoGenomics, Nimagen, Novigenix, OraSure Technologies, Oxford Nanopore Technologies, PathoQuest, PierianDx, Precision System Science, QuantuMDx, Randox Laboratories, SCIENION, Seegene, SpeeDX, Sysmex, and Xagenic.

Commenting on the report, an analyst from the research team said: “One trend in the market is growing focus on next-generation products. The increasing focus on developing next-generation products in the field of POC molecular diagnostics will lead to the increasing adoption of those products. The advances in technology will decrease the workload of end-users and help in offering results within limited time.”

According to the report, one driver in the market is increased companies' participation in conferences to showcase their products. Companies that provide accurate and appropriate POC molecular diagnostic products are focusing on participating in conferences and events, which help them to showcase their products. The rising participation in such type of events provides an insight into the latest trends that pertain in the global POC molecular diagnostics market. It also provides a perception of latest technology, which enables the POC products for molecular diagnosis to carry out the test more efficiently.

Further, the report states that one challenge in the market is low adoption among healthcare providers. The cost of analyzers and assays (POC molecular diagnostics) are high, which hinders the growth of the global POC molecular diagnostics market, as it reduces the adoption rate among healthcare providers. Healthcare providers, particularly in rural areas depend on laboratory-based molecular testing. The other factor that leads to the low adoption of POC molecular diagnostic products within the healthcare providers is the minimal reimbursements.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Abbott
  • bioMérieux
  • Danaher
  • F. Hoffmann-La Roche
  • Agilent Technologies
  • Akonni Biosystems
  • altona Diagnostics
  • Atlas Genetics
  • BD
  • Bionano Genomics
  • BJS Biotechnologies
  • Certest Biotec
  • Co-Diagnostics
  • Devyser
  • Diagenode
  • DiaSorin
  • ExcitePCR
  • genedrive
  • GenePOC
  • iCubate
  • Illumina
  • Merck
  • Meridian Bioscience
  • Mesa Biotech
  • Micronics
  • Nanobiosym
  • NeoGenomics
  • Nimagen
  • Novigenix
  • OraSure Technologies
  • Oxford Nanopore Technologies
  • PathoQuest
  • PierianDx
  • Precision System Science
  • QuantuMDx
  • Randox Laboratories
  • SCIENION
  • Seegene
  • SpeeDX
  • Sysmex
  • Xagenic
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll